Iridex (IRIX) Total Non-Current Liabilities (2011 - 2026)
Iridex (IRIX) posted quarterly Total Non-Current Liabilities of $23.1 million for Q2 2026, down 14.73% year-over-year from $27.1 million in Q2 2025, and down 3.1% quarter-over-quarter from $23.8 million in Q1 2026.
Iridex (IRIX) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Iridex's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $23.1 million for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 14.73% year-over-year to $23.1 million; the TTM figure through Apr 2026 stood at $23.1 million (down 14.73% YoY), while the FY2026 annual figure was $23.8 million, down 10.78% from the prior year.
- Total Non-Current Liabilities for Q2 2026 stood at $23.1 million, down from $23.8 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $27.3 million in Q1 2024, with the low at $22.7 million in Q3 2023.
- The 5-year median for Total Non-Current Liabilities is $25.3 million (2022), against an average of $25.4 million.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities surged 139.7% in 2022, then decreased 15.3% in 2023.
- Iridex's Total Non-Current Liabilities stood at $25.0 million in 2022, then decreased by 1.13% to $24.8 million in 2023, then increased by 7.98% to $26.7 million in 2024, then slipped by 12.6% to $23.4 million in 2025, then declined by 1.09% to $23.1 million in 2026.
- Business Quant data shows IRIX's Total Non-Current Liabilities at $23.1 million in Q2 2026, $23.8 million in Q1 2026, and $23.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Iridex | 13.27 Mn | 8.59 Mn | 4.30 Mn | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 23.10 Mn |
| Jan 3, 2026 | 23.84 Mn |
| Sep 27, 2025 | 23.36 Mn |
| Jun 28, 2025 | 25.22 Mn |
| Mar 29, 2025 | 27.09 Mn |
| Dec 28, 2024 | 26.72 Mn |
| Sep 28, 2024 | 27.21 Mn |
| Jun 29, 2024 | 26.70 Mn |
| Mar 30, 2024 | 27.30 Mn |
| Dec 30, 2023 | 24.75 Mn |
| Sep 30, 2023 | 22.75 Mn |
| Jul 1, 2023 | 23.46 Mn |
| Apr 1, 2023 | 24.97 Mn |
| Dec 31, 2022 | 25.03 Mn |
| Oct 1, 2022 | 26.86 Mn |
| Jul 2, 2022 | 26.19 Mn |
| Apr 2, 2022 | 26.67 Mn |
| Jan 1, 2022 | 25.36 Mn |
| Oct 2, 2021 | 25.20 Mn |
| Jul 3, 2021 | 23.62 Mn |